Carmustine April 12, 2017 Carmustine Trade Name Orphan Indication Intracranial malignancies USA Market Approval USA USA Designation Date 2000-07-03 00:00:00 Sponsor Direct Therapeutics, Inc.;460 Seaport Court, Suite 220;Redwood, California, 94063
